In the sensitivity analyses, the results did not significantly change when further adjusted for lipid-lowering drugs, CRP levels, and sleep pattern score or after excluding incident CHD events within 2 years among individuals with diabetes and individuals with prediabetes. This evidence concerns the gene CRP and diabetes mellitus.